N. Anfossi, P. André, S. Guia, C. S. Falk, S. Roetynck et al., Human NK cell education by inhibitory receptors for MHC class I, Immunity, vol.25, p.16901727, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00165596

L. Araujo, P. Khim, H. Mkhikian, C. L. Mortales, and M. Demetriou, Glycolysis and glutaminolysis cooperatively control T cell function by limiting metabolite supply to N-glycosylation, vol.6, p.28059703, 2017.

P. Brodin, T. Lakshmikanth, S. Johansson, K. Kä-rre, H. et al., The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells, Blood, vol.113, p.18974374, 2009.

P. Brodin, K. Kä-rre, H. , and P. , NK cell education: not an on-off switch but a tunable rheostat, Trends in Immunology, vol.30, p.19282243, 2009.

P. Chappert and R. H. Schwartz, Induction of T cell anergy: integration of environmental cues and infectious tolerance, Current Opinion in Immunology, vol.22, p.20869863, 2010.

R. P. Donnelly, R. M. Loftus, S. E. Keating, K. T. Liou, C. A. Biron et al., mTORC1-dependent metabolic reprogramming is a prerequisite for NK cell effector function, The Journal of Immunology, vol.193, p.25261477, 2014.

P. M. Dubois, M. Pihlgren, M. Tomkowiak, M. Van-mechelen, and M. J. , Tolerant CD8 T cells induced by multiple injections of peptide antigen show impaired TCR signaling and altered proliferative responses in vitro and in vivo, Journal of Immunology, vol.161, p.9820498, 1998.

T. Ebihara, A. H. Jonsson, and W. M. Yokoyama, Natural killer cell licensing in mice with inducible expression of MHC class I, PNAS, vol.110, p.24145414, 2013.

A. Efeyan, W. C. Comb, and D. M. Sabatini, Nutrient-sensing mechanisms and pathways, Nature, vol.517, p.25592535, 2015.

J. M. Elliott, J. A. Wahle, and W. M. Yokoyama, MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment, The Journal of Experimental Medicine, vol.207, p.20819924, 2010.

N. C. Fernandez, E. Treiner, R. E. Vance, A. M. Jamieson, S. Lemieux et al., A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules, Blood, vol.105, p.15728129, 2005.

S. Fried, B. Reicher, M. H. Pauker, S. Eliyahu, O. Matalon et al., Triple-color FRET analysis reveals conformational changes in the WIP-WASp actin-regulating complex, Science Signaling, vol.7, p.24962707, 2014.

J. M. García-martínez, J. Moran, R. G. Clarke, A. Gray, S. C. Cosulich et al., Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR), Biochemical Journal, vol.421, p.19402821, 2009.

S. Guia, B. N. Jaeger, S. Piatek, S. Mailfert, T. Trombik et al., Confinement of activating receptors at the plasma membrane controls natural killer cell tolerance, Science Signaling, vol.4, p.21467299, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00609667

S. M. Guichard, J. Curwen, T. Bihani, D. Cruz, C. M. Yates et al., AZD2014, an inhibitor of mTORC1 and mTORC2, is highly effective in ER+ breast cancer when administered using intermittent or continuous schedules, Molecular Cancer Therapeutics, vol.14, p.26358751, 2015.

A. Hagiwara, M. Cornu, N. Cybulski, P. Polak, C. Betz et al., Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c, Cell Metabolism, vol.15, p.22521878, 2012.

T. Hanke, H. Takizawa, C. W. Mcmahon, D. H. Busch, E. G. Pamer et al., Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors, Immunity, vol.11, p.10435580, 1999.

P. G. Hogan and A. Rao, Store-operated calcium entry: Mechanisms and modulation, Biochemical and Biophysical Research Communications, vol.460, p.998732, 2015.

W. Huang, P. J. Zhu, S. Zhang, H. Zhou, L. Stoica et al., mTORC2 controls actin polymerization required for consolidation of long-term memory, Nature Neuroscience, vol.16, p.23455608, 2013.

P. Hö-glund and P. Brodin, Current perspectives of natural killer cell education by MHC class I molecules, Nature Reviews Immunology, vol.10, p.20818413, 2010.

M. H. Johansson, C. Bieberich, G. Jay, K. Kä-rre, H. et al., Natural killer cell tolerance in mice with mosaic expression of major histocompatibility complex class I transgene, The Journal of Experimental Medicine, vol.186, p.9236187, 1997.

S. Johansson, M. Johansson, E. Rosmaraki, G. Vahlne, R. Mehr et al., Natural killer cell education in mice with single or multiple major histocompatibility complex class I with the number of inhibitory receptors for self-MHC class I: the rheostat model, The Journal of Immunology, vol.182, p.19342631, 2005.

N. T. Joncker, N. Shifrin, F. Delebecque, and D. H. Raulet, Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment, The Journal of Experimental Medicine, vol.207, p.20819928, 2010.

M. P. Keppel, N. Saucier, A. Y. Mah, T. P. Vogel, and M. A. Cooper, Activation-specific metabolic requirements for NK Cell IFN-g production, The Journal of Immunology, vol.194, p.25595780, 2015.

S. Kim, J. Poursine-laurent, S. M. Truscott, L. Lybarger, Y. J. Song et al., Licensing of natural killer cells by host major histocompatibility complex class I molecules, Nature, vol.436, p.16079848, 2005.
DOI : 10.1038/nature03847

B. H. Koller, P. Marrack, J. W. Kappler, and O. Smithies, Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells, Science, vol.248, p.2112266, 1990.

K. Krzewski, X. Chen, J. S. Orange, and J. L. Strominger, Formation of a WIP-, WASp-, actin-, and myosin IIAcontaining multiprotein complex in activated NK cells and its alteration by KIR inhibitory signaling, The Journal of Cell Biology, vol.173, p.16606694, 2006.

K. Lee, P. Gudapati, S. Dragovic, C. Spencer, S. Joyce et al., Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways, Immunity, vol.32, p.941, 2010.

R. J. Li, J. Xu, C. Fu, J. Zhang, Y. G. Zheng et al., Regulation of mTORC1 by lysosomal calcium and calmodulin, vol.5, p.27787197, 2016.
DOI : 10.7554/elife.19360
URL : https://cdn.elifesciences.org/articles/19360/elife-19360-v2.pdf

Q. Liu, J. Wang, S. A. Kang, C. C. Thoreen, W. Hur et al., Discovery of 9-(6aminopyridin-3-yl)-1-(3-(trifluoromethyl)phenyl)benzo[h][1,6]naphthyridin-2(1H)-one (Torin2) as a potent, selective, and orally available mammalian target of rapamycin (mTOR) inhibitor for treatment of cancer, Journal of Medicinal Chemistry, vol.54, p.21322566, 2011.

A. Marcais, R. Blevins, J. Graumann, A. Feytout, G. Dharmalingam et al., microRNA-mediated regulation of mTOR complex components facilitates discrimination between activation and anergy in CD4 T cells, The Journal of Experimental Medicine, vol.211, p.25311506, 2014.
URL : https://hal.archives-ouvertes.fr/pasteur-01091088

A. Març-ais, J. Cherfils-vicini, C. Viant, S. Degouve, S. Viel et al., The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells, Nature Immunology, vol.15, p.24973821, 2014.

P. K. Mattila, F. D. Batista, and B. Treanor, Dynamics of the actin cytoskeleton mediates receptor cross talk: An emerging concept in tuning receptor signaling, The Journal of Cell Biology, vol.212, p.26833785, 2016.

J. Michaë-lsson, A. Achour, M. Salcedo, A. Kâ-se-sjö-strö-m, J. Sundbä-ck et al., Visualization of inhibitory Ly49 receptor specificity with soluble major histocompatibility complex class I tetramers, European Journal of Immunology, vol.30, p.10602053, 2000.

A. E. Moran, K. L. Holzapfel, Y. Xing, N. R. Cunningham, J. S. Maltzman et al., T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse, The Journal of Experimental Medicine, vol.208, pp.2160650-2160658, 2011.
DOI : 10.1084/jem.20110308
URL : http://jem.rupress.org/content/208/6/1279.full.pdf

A. J. Morgan, F. M. Platt, E. Lloyd-evans, and A. Galione, Molecular mechanisms of endolysosomal Ca2+ signalling in health and disease, Biochemical Journal, vol.439, pp.349-378, 2011.

D. E. Oppenheim, S. J. Roberts, S. L. Clarke, R. Filler, J. M. Lewis et al., Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance, Nature Immunology, vol.6, p.16116470, 2005.

R. Parameswaran, P. Ramakrishnan, S. A. Moreton, Z. Xia, Y. Hou et al., Repression of GSK3 restores NK cell cytotoxicity in AML patients, Nature Communications, vol.7, p.27040177, 2016.
DOI : 10.1038/ncomms11154
URL : http://www.nature.com/articles/ncomms11154.pdf

D. M. Sabatini, H. Erdjument-bromage, M. Lui, P. Tempst, and S. H. Snyder, RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs, Cell, vol.78, p.7518356, 1994.
DOI : 10.1016/0092-8674(94)90570-3

D. D. Sarbassov, S. M. Ali, D. H. Kim, D. A. Guertin, R. R. Latek et al., Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton, The Journal of Experimental Medicine, vol.14, p.15809355, 2004.

N. T. Joncker, N. C. Fernandez, E. Treiner, E. Vivier, and D. H. Raulet, NK cell responsiveness is tuned commensurate, 2009.

L. V. Sinclair, J. Rolf, E. Emslie, Y. B. Shi, P. M. Taylor et al., Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation, Nature Immunology, vol.14, p.23525088, 2013.

H. Spits, D. Artis, M. Colonna, A. Diefenbach, D. Santo et al., Innate lymphoid cells-a proposal for uniform nomenclature, Nature Reviews Immunology, vol.13, p.23348417, 2013.
DOI : 10.1038/nri3365

J. C. Sun and L. L. Lanier, Cutting edge: viral infection breaks NK cell tolerance to "missing self, The Journal of Immunology, vol.181, p.19017932, 2008.

C. M. Sungur, Y. J. Tang-feldman, E. Ames, M. Alvarez, M. Chen et al., Murine natural killer cell licensing and regulation by T regulatory cells in viral responses, PNAS, vol.110, p.23589894, 2013.
DOI : 10.1073/pnas.1218767110
URL : http://www.pnas.org/content/110/18/7401.full.pdf

L. M. Thomas, M. E. Peterson, and E. O. Long, Cutting edge: NK cell licensing modulates adhesion to target cells, The Journal of Immunology, vol.191, p.24038086, 2013.
DOI : 10.4049/jimmunol.1301159
URL : http://europepmc.org/articles/pmc3795972?pdf=render

S. K. Tripathy, P. A. Keyel, L. Yang, J. T. Pingel, T. P. Cheng et al., Continuous engagement of a self-specific activation receptor induces NK cell tolerance, The Journal of Experimental Medicine, vol.205, p.18606857, 2008.

S. H. Um, D. 'alessio, D. , and T. G. , Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1, Cell Metabolism, vol.3, p.16753575, 2006.
DOI : 10.1016/j.cmet.2006.05.003
URL : https://doi.org/10.1016/j.cmet.2006.05.003

R. E. Vance, J. R. Kraft, J. D. Altman, P. E. Jensen, and D. H. Raulet, Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b), The Journal of Experimental Medicine, vol.188, p.9815261, 1998.

C. Viant, A. Fenis, G. Chicanne, B. Payrastre, S. Ugolini et al., SHP-1-mediated inhibitory signals promote responsiveness and anti-tumour functions of natural killer cells, Nature Communications, vol.5, p.25355530, 2014.

S. Viel, A. Guimaraes, F. S. Loftus, R. Rabilloud, J. Grau et al., TGF-b inhibits the activation and functions of NK cells by repressing the mTOR pathway, Science Signaling, vol.9, p.26884601, 2016.

E. Vivier, E. Tomasello, M. Baratin, T. Walzer, and S. Ugolini, Functions of natural killer cells, Nature Immunology, vol.9, p.18425107, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00294184

M. F. Wu and D. H. Raulet, Class I-deficient hemopoietic cells and nonhemopoietic cells dominantly induce unresponsiveness of natural killer cells to class I-deficient bone marrow cell grafts, Journal of immunology, vol.158, p.9029098, 1997.

H. Yang, D. G. Rudge, J. D. Koos, B. Vaidialingam, H. J. Yang et al., mTOR kinase structure, mechanism and regulation, Nature, vol.497, p.23636326, 2013.
DOI : 10.1038/nature12122
URL : http://europepmc.org/articles/pmc4512754?pdf=render

Y. Zheng, S. L. Collins, M. A. Lutz, A. N. Allen, T. P. Kole et al., A role for mammalian target of rapamycin in regulating T cell activation versus anergy, The Journal of Immunology, vol.178, p.17277121, 2007.

Y. Zheng, G. M. Delgoffe, C. F. Meyer, W. Chan, and J. D. Powell, Anergic T cells are metabolically anergic, The Journal of Immunology, vol.183, p.19841171, 2009.
DOI : 10.4049/jimmunol.0803510
URL : http://www.jimmunol.org/content/183/10/6095.full.pdf

J. Zimmer, L. Donato, D. Hanau, J. P. Cazenave, M. M. Tongio et al., Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome), The Journal of Experimental Medicine, vol.187, p.9419217, 1998.